FDA Inspection 1214367 — CCRM Boston
The FDA completed an inspection of CCRM Boston on Jul 20, 2023 in Chestnut Hill, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 20, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Chestnut Hill, MA (United States)